HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

Italy Microbial Transglutaminase Market Size & Outlook, 2025-2033


Italy Microbial Transglutaminase Market Insights

  • Reed Intelligence analysis indicates that the Italy Microbial Transglutaminase Market size, valued at USD 3.54 Million in 2024, is expected to expand to USD 8.28 Million by 2033.
  • The Italy market is forecasted to expand at a CAGR of 9.89% spanning 2026–2033.
  • Streptomyces Mobaraense held the leading position among By Source segments in 2024, based on market size.
  • Streptoverticillium Griseocarneum is projected to post the fastest growth rate, sustaining its position as the most attractive By Source segment during the forecast horizon.

Other Key Findings


  • In 2024, Italy accounted for 2.59% of the global Microbial Transglutaminase Market size.
  • By 2033, United States is expected to lead the global Microbial Transglutaminase Market in terms of market size.
  • Within Europe, Germany is projected to dominate the regional Microbial Transglutaminase Market size by 2033.
  • Nordic is identified as the fastest-growing market in Europe, anticipated to reach USD 3.57 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 3.54 Million
Market Size In 2033 USD 8.28 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 9.89% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports